Radiobotics Gains FDA 510(k) for Knee Osteoarthritis Analysis Tool

FDA granted 510(k) clearance of Radiobotics’ RBknee™ product, an AI-based analysis tool aimed at improving the efficiency and accuracy of radiographic knee osteoarthritis (OA) diagnosis.

Earlier this year, Radiobotics unveiled its commitment to the U.S. market with its first subsidiary, Radiobotics Inc.

The OA product RBknee works by...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us